Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
24,369,589
-
Shares change
-
-3,692,326
-
Total reported value, excl. options
-
$48,741,264
-
Value change
-
-$10,349,986
-
Number of buys
-
38
-
Number of sells
-
-46
-
Price
-
$2.00
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2019
94 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2019.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,369,589 shares
of 44,666,667 outstanding shares and own 55% of the company stock.
Largest 10 shareholders include DIMENSIONAL FUND ADVISORS LP (2,118,753 shares), Engine Capital Management, LP (1,868,048 shares), ROYCE & ASSOCIATES LP (1,829,800 shares), VANGUARD GROUP INC (1,791,842 shares), BlackRock Inc. (1,448,677 shares), DALTON GREINER HARTMAN MAHER & CO (1,155,376 shares), MILLENNIUM MANAGEMENT LLC (1,067,337 shares), ACADIAN ASSET MANAGEMENT LLC (1,052,028 shares), HEARTLAND ADVISORS INC (1,000,000 shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (923,773 shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.